Hotel stocks reported a combined core profit of Bt3,767m for 2Q25 (+0.4% yoy, +101.3% qoq), mainly supported by MINT’s strong hotel performance in Europe. However, Thai tourism’s 3Q25 outlook should remain dull, similar to 2Q25. Hopes of hotel operators rest on the high travel season in 4Q25, as room bookings still indicate a positive momentum. MINT remains our top pick given its lower cost of debt. Maintain MARKET WEIGHT.
The tone of the meeting was slightly positive. Management revised down this year’s revenue growth target, but we view this as reasonable given the current situation. We expect to see an improvement in the outlook from 3Q25 onwards as the forward hotel bookings in Thailand and the Maldives suggest a smaller yoy decline. We expect 3Q25 to be another challenging quarter for CENTEL, but we are becoming more optimistic given the signs of recovery. Maintain BUY. Target price: Bt33.00.
KEY HIGHLIGHTS Results Bangkok Chain Hospital (BCH TB/BUY/Bt14.10/Target: Bt17.50) 2Q25: Reported strong earnings as expected. Update Central Pattana (CPN TB/BUY/Bt54.50/Target: Bt79.60) Favourable 2H25 outlook anchored by core business resilience. Central Plaza Hotel (CENTEL TB/BUY/Bt27.00/Target: Bt33.00) Expect a gradual improvement in outlook. Charoen Pokphand Foods (CPF TB/HOLD/Bt24.40/Target: Bt24.00) 2Q25 earnings in line; 3Q25 earnings momentum to soften. The Erawan ...
GREATER CHINA Economics Economic Activity: Growth decelerates as trade war impact deepens. Results Chongqing Brewery (600132 CH/BUY/Rmb55.26/Target: Rmb67.40): 2Q25: Volume remained flat but ASP dropped 2% yoy; expanding off-trade channel to offset the weakness in on-trade channel. CSPC Innovation Pharmaceutical Co (300765 CH/HOLD/Rmb53.00/Target: Rmb52.00): 1H25: Results in line, smooth progress in R&D. Update Foxconn Industrial Internet (601138 CH/BUY/Rmb44.86/Target: Rmb49.50): Solid 3Q guida...
We expect CENTEL to report a net profit of Bt157m (-6.0% yoy, -78.9% qoq) for 2Q25. The hotel segment’s performance was able to maintain its RevPar to be flat yoy thanks to strong growth in Japan and upcountry hotels. However, the expenses from opening the new hotel at the Maldives will cause the earnings to contract yoy. We expect 3Q25 to be another challenging quarter for CENTEL as there will be fewer supporting factors. Maintain BUY. Target price: Bt33.00.
KEY HIGHLIGHTS Results Bangchak Corporation (BCP TB/BUY/Bt34.00/Target: Bt45.00) 2Q25: Net loss as expected but a sharp rebound is likely in 2H25. Bangchak Sriracha (BSRC TB/BUY/Bt5.00/Target: Bt7.00) 2Q25: Huge inventory loss results in net loss in 2Q25. PTT Oil & Retail Business (OR TB/BUY/Bt12.90/Target: Bt20.00) 2Q25: Net profit in line with our forecast but 14% below consensus’. Upgrade to BUY. Tidlor Holdings (TIDLOR TB/HOLD/Bt18.30/Target: Bt20.00) 2...
We attended CENTEL’s 1Q25 analyst meeting and the tone was slightly negative. Management revised down its 2025 guidance as a result of the weak outlook for hotels in Bangkok and the Maldives as well as the softened performance of food brands. We believe 2Q25 will be a challenging quarter for CENTEL as it will need to rely heavily on the performance of hotels in the upcountry area and in Osaka to see decent earnings. Maintain BUY. Target price: Bt29.00.
KEY HIGHLIGHTS Results CH Karnchang (CK TB/BUY/Bt14.00/Target: Bt20.20) 1Q25: Earnings improve yoy and qoq, beating expectations. Stecon Group (STECON TB/BUY/Bt7.00/Target: Bt9.00) 1Q25: Exceeded expectations; outlook remains positive. Update Airports of Thailand (AOT TB/HOLD/Bt35.00/Target: Bt39.00) Concerns on earnings miss have been alleviated. Central Plaza Hotel (CENTEL TB/BUY/Bt21.30/Target: Bt29.00) A challenging 2Q25 awaits. Charoen Po...
GREATER CHINA Sector Automobile: Weekly: PEV sales edged up wow. Maintain MARKET WEIGHT on the sector. Top BUYs: BYD, Geely and Desay SV. Healthcare: The rising robotic surgical system market in China. Results Alibaba Group (9988 HK/BUY/HK$128.90/Target: HK$165.00): 4QFY25: Slight earnings miss; CMR delivers better-than-expected double-digit growth. Geely Auto (175 HK/BUY/HK$19.58/Target: HK$31.00): 1Q25: Earnings beat on forex gain and associate profit. Maintain BUY. Raise target price to HK$31...
We expect CENTEL to report a report a net profit of Bt721m (-4.5% yoy, +8.1% qoq) for 1Q25. The hotel segment’s performance during the quarter was strong, particularly that of upcountry hotels. However, pre-opening expenses of the new hotel in the Maldives will be realised in 1Q25, along with a substantial exchange loss in Japanese yen-denominated loans. We expect 2Q25 to be a challenging quarter for CENTEL given several headwinds. Maintain BUY. Target price: Bt36.00.
KEY HIGHLIGHTS Sector Construction 1Q25 results preview: CK and STECON set to rebound. Results IRPC (IRPC TB/BUY/Bt0.94/Target: Bt1.10) 1Q25: Net loss deepens on lower margins, but share price already reflects bad news. LPN Development (LPN TB/SELL/Bt2.06/Target: Bt1.50) 1Q25: Results slightly beat expectation, but recovery remains...
We attended CENTEL’s 4Q24 analyst meeting and the tone was slightly positive. 4Q24 earnings came in at Bt667m (+124.9% yoy, +309.0% qoq) and exceeded our and consensus expectations. One of the key contributors is the strong growth from Shinkanzen Sushi, one of CENTEL’s most profitable JVs. CENTEL has provided a growth guidance for 2025 and the outlook for 1H25 is promising. Maintain BUY. Target price: Bt36.00.
KEY HIGHLIGHTS Results Betagro (BTG TB/BUY/Bt18.50/Target: Bt24.20) 4Q24: Earnings in line; expect stronger 1Q25 earnings. Bangkok Dusit Medical Services (BDMS TB/BUY/Bt26.50/Target: Bt33.00) 4Q24: Robust quarterly earnings; in line. Land and Houses (LH TB/HOLD/Bt4.54/Target: Bt5.20) 4Q24: One-off items underpinned performance; residential business remains weak. Srisawad Corporation (SAWAD TB/HOLD/Bt40.50/Target: Bt38.00) 4Q24: Results mis...
GREATER CHINA Economics Hong Kong Budget 2025-26 The budget balances fiscal discipline with strategic growth initiatives. Results ASMPT (522 HK/BUY/HK$64.05/Target: HK$80.00) 4Q24: Earnings disappoint; mainstream tools recovering in 2025 but visibility remains low. Maintain BUY. Budweiser APAC (1876 HK/BUY/HK$8.66/Target: HK$13.30) 4Q24: Results miss slightly; CEO change and increased shareho...
We expect CENTEL to report a net profit of Bt350m (-17.6% yoy, +114.6% qoq) for 4Q24. Its top-line should see a yoy growth due to robust hotel performances in Bangkok and Japan. Major renovations at Karon and Mirage have been completed, and both have resumed operations with increased room rates. Most expenses have been realised, and its share price has dropped sharply, which has resulted in upside. Upgrade to BUY. Target price: Bt33.00.
KEY HIGHLIGHTS Update Bumrungrad Hospital (BH TB/BUY/Bt175.50/Target: Bt232.00) Weak 4Q24 earnings expected. Central Plaza Hotel (CENTEL TB/BUY/Bt28.00/Target: Bt33.00) Reaching a turning point; upgrade to BUY. Central Pattana (CPN TB/BUY/Bt52.25/Target: Bt79.30) Expect 4Q24 earnings to be pressured by SG&A, but 2024 is set to deliver a record profit.
GREATER CHINA Sector Automobile Weekly: PV sales stay low, BYD to equip all EVs with DiPilot ADAS. Upgrade BYD to BUY. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Update AAC Technologies (2018 HK/HOLD/HK$46.55/ Target: HK$48.00) 2024 profit alert – earnings set to beat expectations. Maintain HOLD. The United Laboratories International (3933 HK/HOLD/HK$12.42/Target: H...
GREATER CHINA Strategy Alpha Picks: January Conviction Calls Add CATL, JD Logistics, Miniso and Plover Bay to our BUY list, and Weimob to our SELL list. INDONESIA Strategy Alpha Picks: Our Selections Outperform In 2024 Our picks are ISAT, KLBF, BMRI, BBRI, EXCL, CTRA, JSMR, BBNI, CMRY and ASII. MALAYSIA Update VS Industry (VSI MK/BUY/RM1.16/Target: RM1.50) Despite a 17% recovery in its share price since its low in m...
Hotel stocks reported a combined core profit of Bt2,924m for 3Q24 (+17.1% yoy, -17.6% qoq), mainly on the back of MINT’s robust hotel performance during the high travel season in Europe. Now that it is the high travel season, we expect all hotel operators to perform well in terms of operations. In 4Q24 thus far, the statistics have been decent even without any significant tourism stimulus measures. We expect to see strong results from MINT and ERW. Maintain MARKET WEIGHT. Our top pick is MINT.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.